Abstract

Aims: Hypertension increases the risk of heart disease. Hallmark features of hypertensive heart disease is sympathoexcitation and cardiac mitochondrial abnormality. However, the molecular mechanisms for specifically neurally mediated mitochondrial abnormality and subsequent cardiac dysfunction are unclear. We hypothesized that enhanced sympatho-excitation to the heart elicits cardiac miR-18a-5p/HIF-1α and mitochondrial unfolded protein response (UPRmt) signaling that lead to mitochondrial abnormalities and consequent pathological cardiac remodeling.Methods and Results: Using a model of neurogenic hypertension (NG-HTN), induced by intracerebroventricular (ICV) infusion of Ang II (NG-HTN; 20 ng/min, 14 days, 0.5 μl/h, or Saline; Control, 0.9%) through osmotic mini-pumps in Sprague-Dawley rats (250–300 g), we attempted to identify a link between sympathoexcitation (norepinephrine; NE), miRNA and HIF-1α signaling and UPRmt to produce mitochondrial abnormalities resulting in cardiomyopathy. Cardiac remodeling, mitochondrial abnormality, and miRNA/HIF-1α signaling were assessed using histology, immunocytochemistry, electron microscopy, Western blotting or RT-qPCR. NG-HTN demonstrated increased sympatho-excitation with concomitant reduction in UPRmt, miRNA-18a-5p and increased level of HIF-1α in the heart. Our in silico analysis indicated that miR-18a-5p targets HIF-1α. Direct effects of NE on miRNA/HIF-1α signaling and mitochondrial abnormality examined using H9c2 rat cardiomyocytes showed NE reduces miR-18a-5p but increases HIF-1α. Electron microscopy revealed cardiac mitochondrial abnormality in NG-HTN, linked with hypertrophic cardiomyopathy and fibrosis. Mitochondrial unfolded protein response was decreased in NG-HTN indicating mitochondrial proteinopathy and proteotoxic stress, associated with increased mito-ROS and decreased mitochondrial membrane potential (ΔΨm), and oxidative phosphorylation. Further, there was reduced cardiac mitochondrial biogenesis and fusion, but increased mitochondrial fission, coupled with mitochondrial impaired TIM-TOM transport and UPRmt. Direct effects of NE on H9c2 rat cardiomyocytes also showed cardiomyocyte hypertrophy, increased mitochondrial ROS generation, and UPRmt corroborating the in vivo data.Conclusion: In conclusion, enhanced sympatho-excitation suppress miR-18a-5p/HIF-1α signaling and increased mitochondrial stress proteotoxicity, decreased UPRmt leading to decreased mitochondrial dynamics/OXPHOS/ΔΨm and ROS generation. Taken together, these results suggest that ROS induced mitochondrial transition pore opening activates pro-hypertrophy/fibrosis/inflammatory factors that induce pathological cardiac hypertrophy and fibrosis commonly observed in NG-HTN.

Highlights

  • Hypertension is an independent risk factor for heart failure, and is rapidly becoming a prominent threat, since it affects ∼80% of the elderly population (65 years and older) (Lionakis et al, 2012)

  • There was an increase in heart weight (HW)/body weight (BW)(g) ratio (4.5 ± 0.4; NG-HTN vs. 2.8 ± 0.06; Control)

  • Echocardiography measurements showed decreased mitral filing velocity (E/A ratio, NG-HTN: 1.2 ± 0.1 vs. 1.5 ± 0.2; Control), which confirmed that rats with NG-HTN rats (NGHTN) developed diastolic heart failure

Read more

Summary

Introduction

Hypertension is an independent risk factor for heart failure, and is rapidly becoming a prominent threat, since it affects ∼80% of the elderly population (65 years and older) (Lionakis et al, 2012). Plasma levels of norepinephrine (NE) are known to be elevated during both hypertension and heart failure indicating an exaggerated sympatho-excitatory state (Patel et al, 2016). Blocking this exaggerated sympathetic drive with β-blockers has been useful to treat heart failure pathology. Attenuation of heart failure pathology with β-blockers has been attributed to relieving some of the mitochondrial dysfunction (Brown et al, 2017) Consistent with these observations, the β-blocker, carvedilol, has been clinically shown to be cardioprotective by improving mitochondrial metabolism and function (Igarashi et al, 2006). The underlying molecular mechanisms linking sympatho-excitation and cardiac dysfunctions directly in hypertension remain unexplored (Eirin et al, 2018)

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call